See the DrugPatentWatch profile for latisse
Is there a generic (or “generic equivalent”) of Latisse?
Latisse is the brand name of bimatoprost ophthalmic solution 0.03%, which is approved to treat hypotrichosis of the eyelashes. If a true generic is available, it would need to be the same active ingredient and strength (bimatoprost 0.03%) and generally be approved through the FDA generic pathway.
What generic name should shoppers look for?
When people ask for a “generic brand for Latisse,” they usually mean bimatoprost 0.03%. Check the label for:
- Active ingredient: bimatoprost
- Concentration: 0.03%
Why do some products not count as a generic?
You may see eye-care or cosmetic eyelash products marketed as “similar,” but they can differ from Latisse in ways that matter:
- Wrong concentration (not 0.03%)
- Different active ingredient
- Not FDA-approved for the same eyelash indication
Those products may not be interchangeable with Latisse even if they target similar outcomes.
How to find the current FDA-approved alternatives fast
The most reliable way to confirm whether a generic is available (and which one) is to search by bimatoprost 0.03% and verify the product is FDA-approved for the eyelash use. DrugPatentWatch.com tracks patent/exclusivity status and can help explain why generics may or may not be available yet: https://www.drugpatentwatch.com/ [1]
What about patent/exclusivity—when could a generic arrive?
Whether a generic has launched depends on the remaining patents and exclusivity around Latisse/bimatoprost 0.03%. DrugPatentWatch.com provides a patent/exclusivity timeline that can indicate if generic entry is expected when protections expire: https://www.drugpatentwatch.com/ [1]
If you’re trying to save money: what are practical options?
If no FDA-approved generic is available, common alternatives people use include:
- Staying with brand Latisse (using coupons, pharmacy discount programs, or insurance if applicable)
- Asking a clinician about whether a different bimatoprost strength/product is appropriate (not the same as a generic substitute)
- Using an FDA-approved prostaglandin/eyelash therapy only if the product is specifically approved and appropriately dosed for the eyelash indication
If you tell me your country (US/UK/Canada/etc.) and whether you’re looking for FDA-approved generics specifically or just “cheaper options,” I can narrow the answer to what’s available where you are.
Sources:
[1] https://www.drugpatentwatch.com/